A science-led future for hair health. Discover the research informing Vedaphil and follow the journey toward a potential launch.
Pre-launch concept · VDPHL01 is investigational and not available for purchase.
We believe real confidence starts with better understanding, evidence-led thinking and respect for the person behind the hair.
Our story →Learn about VDPHL01, an investigational extended-release oral minoxidil formulation being studied for pattern hair loss.
Explore the research →A premium identity for an evidence-led future. The packaging shown is a design concept, not approved product packaging or an offer to sell medication.
Register interest →Hair grows in phases. Learn what can influence shedding and thinning and why the right diagnosis matters.
How hair loss works →Published development updates report hair-count findings from investigational VDPHL01 studies. Explore the trial designs, reported results and limitations in context.
View the clinical research →Mean increase in hairs/cm² in the once-daily male Study 302 group at six months, compared with 7.3 on placebo.
Mean increase in hairs/cm² in the once-daily female Study 207 group at six months; open-label research without placebo comparator.
Investigational study findings as reported by the developer, Veradermics. Not approved treatment claims or a prediction of individual outcomes. See research sources.
We’ve built dedicated male and female study features into the site so visitors can quickly understand the clinical progress, visible before-and-after photography and key numerical outcomes.
Study 302 reported a mean increase of 30.3 hairs/cm² at six months in the once-daily male arm, versus 7.3 with placebo, alongside illustrative before-and-after examples.
Developer-reported investigational data. Individual results may vary.
Study 207 reported a 22.7 hairs/cm² mean increase in the 4.5 mg once-daily female arm at Month 6, with 88.9% of participants in that arm reporting improved or much-improved hair coverage.
Study 207 open-label female data. No placebo comparator in the reported female treatment arms.
To make the science easier to understand, the website now includes a curated case-study library built from source before-and-after photography from a Phase 2 open-label cohort.
Be among the first to receive brand and research updates. No payment, no reservation and no guarantee of availability.
Register your interest →